KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Tax Provisions (2021 - 2023)

AbCellera Biologics' Tax Provisions history spans 3 years, with the latest figure at -$1.5 million for Q4 2023.

  • For the quarter ending Q4 2023, Tax Provisions rose 4.41% year-over-year to -$1.5 million, compared with a TTM value of -$27.6 million through Dec 2023, down 134.29%, and an annual FY2024 reading of -$37.5 million, down 35.85% over the prior year.
  • Tax Provisions for Q4 2023 was -$1.5 million at AbCellera Biologics, up from -$10.7 million in the prior quarter.
  • The five-year high for Tax Provisions was $62.2 million in Q1 2022, with the low at -$10.7 million in Q3 2023.
  • Average Tax Provisions over 3 years is $9.9 million, with a median of -$776500.0 recorded in 2022.
  • Year-over-year, Tax Provisions soared 655.76% in 2022 and then tumbled 7301.98% in 2023.
  • Tracing ABCL's Tax Provisions over 3 years: stood at $24.8 million in 2021, then plummeted by 106.13% to -$1.5 million in 2022, then increased by 4.41% to -$1.5 million in 2023.
  • Per Business Quant, the three most recent readings for ABCL's Tax Provisions are -$1.5 million (Q4 2023), -$10.7 million (Q3 2023), and -$7.5 million (Q2 2023).